‘A Christmas wish come true’: CBD industry celebrates as EC resumes Novel Food applications More good news for the CBD industry. The European Commission has abandoned its plans to classify non-synthetic CBD a narcotic and resumed Novel Food applications for edible CBD products.
The move came after the European Court of Justice ruled that CBD is not a narcotic drug as it
“does not appear to have any psychotropic effect or any harmful effect on human health”.
This verdict, which related to the prosecution of French e-cigarette company KanaVape, put pressure on the EC to change its decision in June to postpone the progress of CBD Novel Food applications as it decided whether to class non-synthetic CBD as a narcotic.